Invitation to a press conference on Bittium Corporation’s Financial Statement Bulletin 2018

 

Press Release

Free for publication on February 14, 2019 at 1.30pm (CET+1)

Invitation to a press conference on Bittium Corporation’s Financial Statement Bulletin 2018

Bittium Corporation’s Financial Statement Bulletin 2018 will be published on Thursday, February 21, 2019, at 8.00am (CET+1). The release will be available on company’s website www.bittium.com immediately after the publication.

Bittium will hold a press conference for media, analysts and institutional investors on February 21, 2019, at 9.30am (CET+1) in Restaurant Savoy, Eteläesplanadi 14, Helsinki. The conference will be held in Finnish.

Bittium will also hold a webcast and telephone conference for media, analysts and institutional investors on the same day at 11.00am (CET+1). Dial-in number for the conference call is FI: +358981710310 (PIN: 59477240#). The conference can be followed online as webcast in the internet, accessible at https://bittium.videosync.fi/2018-financial-statement-teleconference. The conference call will be held in English.

Instructions on how to participate will be available at www.bittium.com/investors soon.

A recording of the webcast and the presentation will be available after the conference on Bittium’s website at www.bittium.com/investors.

Further information:

Karoliina Fyrstén
Director, Corporate Communications and Marketing
Tel. +358 40 344 2789

Distribution:

Main media
www.bittium.com/investors

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its 30 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2017 were EUR 51.6 million and operating loss was EUR -6.2 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com

Subscribe